Clinical Trial Update: An Evaluation of PDI-320 in Comparison to Its Monads in Adults With Rosacea [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial update evaluating PDI-320 in adults with rosacea, comparing it to its monads.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rosacea

Drugs mentioned

• PDI-320 (PDI-320)

Snippet

Sponsor: PreCision Dermatology, Inc. | Conditions: Rosacea | Phase 2 | Status: UNKNOWN